NATERA, INC. (NTRA) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
67/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinNTRA / S&P 35.73% / 15.20% |
WinNTRA / S&P 37.82% / 15.00% |
LoseNTRA / S&P -29.32% / 50.40% |
| 2026-Q11/3 |
LoseNTRA / S&P -12.70% / -4.33% |
WinNTRA / S&P 36.59% / 11.30% |
LoseNTRA / S&P 10.20% / 27.70% |
| 2025-Q42/3 |
WinNTRA / S&P 42.32% / 2.65% |
WinNTRA / S&P 35.90% / 9.00% |
LoseNTRA / S&P -0.65% / 13.40% |
| 2025-Q32/3 |
LoseNTRA / S&P -4.72% / 8.12% |
WinNTRA / S&P 38.17% / 4.61% |
WinNTRA / S&P 30.11% / 13.45% |
| 2025-Q22/3 |
WinNTRA / S&P 19.47% / 10.94% |
WinNTRA / S&P 44.38% / 4.83% |
LoseNTRA / S&P -22.04% / 10.63% |
| 2025-Q11/3 |
LoseNTRA / S&P -10.67% / -4.27% |
WinNTRA / S&P 51.50% / 4.98% |
LoseNTRA / S&P -52.88% / 10.57% |
| 2024-Q42/3 |
WinNTRA / S&P 24.69% / 2.41% |
WinNTRA / S&P 56.75% / 5.25% |
LoseNTRA / S&P -59.63% / 6.15% |
| 2024-Q32/3 |
WinNTRA / S&P 17.23% / 5.89% |
WinNTRA / S&P 54.94% / 5.89% |
LoseNTRA / S&P -61.06% / 6.11% |
| 2024-Q22/3 |
WinNTRA / S&P 18.40% / 4.28% |
WinNTRA / S&P 46.13% / 5.38% |
LoseNTRA / S&P -49.17% / 5.12% |
| 2024-Q12/3 |
WinNTRA / S&P 46.01% / 10.56% |
WinNTRA / S&P 39.26% / 5.71% |
LoseNTRA / S&P -41.68% / 5.59% |
| 2023-Q42/3 |
WinNTRA / S&P 41.56% / 11.69% |
WinNTRA / S&P 31.99% / 6.81% |
LoseNTRA / S&P -31.96% / 7.78% |
| 2023-Q31/3 |
LoseNTRA / S&P -9.06% / -3.27% |
WinNTRA / S&P 27.41% / 7.52% |
LoseNTRA / S&P -20.56% / -5.03% |
| 2023-Q21/3 |
LoseNTRA / S&P -12.36% / 8.74% |
WinNTRA / S&P 28.69% / 9.50% |
LoseNTRA / S&P -20.59% / -8.57% |
| 2023-Q13/3 |
WinNTRA / S&P 38.21% / 7.50% |
WinNTRA / S&P 30.05% / 10.77% |
WinNTRA / S&P -9.17% / -15.69% |
| 2022-Q42/3 |
LoseNTRA / S&P -8.33% / 7.56% |
WinNTRA / S&P 31.13% / 11.88% |
WinNTRA / S&P 7.53% / -17.99% |
| 2022-Q32/3 |
WinNTRA / S&P 23.65% / -4.88% |
WinNTRA / S&P 37.38% / 13.47% |
LoseNTRA / S&P NTRA unavailable / -1.41% |
| 2022-Q22/3 |
WinNTRA / S&P -12.88% / -16.10% |
WinNTRA / S&P 43.30% / 13.71% |
LoseNTRA / S&P NTRA unavailable / 11.04% |
| 2022-Q11/3 |
LoseNTRA / S&P -56.44% / -4.60% |
WinNTRA / S&P 48.52% / 15.97% |
LoseNTRA / S&P NTRA unavailable / 42.23% |
| 2021-Q41/3 |
LoseNTRA / S&P -16.20% / 11.03% |
WinNTRA / S&P 59.97% / 15.00% |
LoseNTRA / S&P NTRA unavailable / 96.40% |
| 2021-Q31/3 |
LoseNTRA / S&P -1.84% / 0.58% |
WinNTRA / S&P 56.09% / 10.77% |
LoseNTRA / S&P NTRA unavailable / 69.42% |
| 2021-Q22/3 |
WinNTRA / S&P 11.81% / 8.55% |
WinNTRA / S&P 47.78% / 6.58% |
LoseNTRA / S&P NTRA unavailable / 51.81% |
| 2021-Q11/3 |
LoseNTRA / S&P 2.03% / 6.17% |
WinNTRA / S&P 36.35% / -1.06% |
LoseNTRA / S&P NTRA unavailable / 7.39% |
| 2020-Q42/3 |
WinNTRA / S&P 37.76% / 12.15% |
WinNTRA / S&P 29.33% / -3.72% |
LoseNTRA / S&P NTRA unavailable / -33.42% |
| 2020-Q32/3 |
WinNTRA / S&P 44.89% / 8.93% |
WinNTRA / S&P 26.50% / -2.04% |
LoseNTRA / S&P NTRA unavailable / -27.10% |
| 2020-Q22/3 |
WinNTRA / S&P 66.98% / 20.54% |
WinNTRA / S&P 24.95% / -0.46% |
LoseNTRA / S&P NTRA unavailable / -27.11% |
| 2020-Q12/3 |
WinNTRA / S&P -11.37% / -19.60% |
WinNTRA / S&P 25.70% / 3.47% |
LoseNTRA / S&P NTRA unavailable / -14.75% |
| 2019-Q41/3 |
LoseNTRA / S&P 2.71% / 9.07% |
WinNTRA / S&P 17.34% / 5.36% |
LoseNTRA / S&P -18.83% / 2.99% |
| 2019-Q32/3 |
WinNTRA / S&P 18.93% / 1.70% |
WinNTRA / S&P 17.84% / 5.02% |
LoseNTRA / S&P -28.74% / 0.21% |
| 2019-Q22/3 |
WinNTRA / S&P 33.75% / 4.30% |
WinNTRA / S&P 17.16% / 6.64% |
LoseNTRA / S&P -23.48% / 8.65% |
| 2019-Q12/3 |
WinNTRA / S&P 47.71% / 13.65% |
WinNTRA / S&P 17.77% / 8.12% |
LoseNTRA / S&P -15.95% / 14.29% |
| 2018-Q41/3 |
LoseNTRA / S&P -41.69% / -13.52% |
WinNTRA / S&P 24.38% / 9.05% |
LoseNTRA / S&P -14.56% / 18.23% |
| 2018-Q32/3 |
WinNTRA / S&P 27.21% / 7.71% |
WinNTRA / S&P 21.47% / 10.21% |
LoseNTRA / S&P 2.76% / 19.06% |
| 2018-Q22/3 |
WinNTRA / S&P 103.02% / 3.43% |
WinNTRA / S&P 17.98% / 9.03% |
LoseNTRA / S&P 4.76% / 14.46% |
| 2018-Q12/3 |
WinNTRA / S&P 3.11% / -0.76% |
WinNTRA / S&P 12.69% / 7.68% |
LoseNTRA / S&P 5.76% / 12.46% |
| 2017-Q41/3 |
LoseNTRA / S&P -30.26% / 6.64% |
LoseNTRA / S&P -2.53% / 7.03% |
WinNTRA / S&P 33.85% / 13.82% |
| 2017-Q32/3 |
WinNTRA / S&P 18.69% / 4.48% |
LoseNTRA / S&P -9.45% / 5.68% |
WinNTRA / S&P 98.44% / 17.57% |
| 2017-Q22/3 |
WinNTRA / S&P 22.44% / 3.09% |
LoseNTRA / S&P -6.57% / 4.83% |
WinNTRA / S&P 115.38% / 17.74% |
| 2017-Q10/3 |
LoseNTRA / S&P -24.25% / 6.07% |
LoseNTRA / S&P -3.57% / 3.67% |
LoseNTRA / S&P NTRA unavailable / 13.32% |
| 2016-Q42/3 |
WinNTRA / S&P 5.40% / 3.82% |
WinNTRA / S&P 11.64% / 2.09% |
LoseNTRA / S&P NTRA unavailable / 7.05% |
| 2016-Q31/3 |
LoseNTRA / S&P -7.92% / 3.85% |
WinNTRA / S&P 17.81% / 0.20% |
LoseNTRA / S&P NTRA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | NTRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 101.31% | 20.78% |
| Annualized return | 101.31% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | NTRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 178.03% | 83.14% |
| Annualized return | 22.69% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | NTRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 3266.80% | 319.30% |
| Annualized return | 42.14% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |